Description

Product information

IUPAC-name   N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amin

Synonyms     5-MeO-MiPT, 5-methoxy MiPT

Formal name  5-methoxy-N-methyl-N-(1-methylethyl)-1H-Indole-3-ethanamine

Cas number    96096-55-8

Formula   C₁₅H₂₂N₂O

Molar Mass   246.354 g·mol⁻¹

Purity     99.0 % min.

Formulations    A neat solid, Powder

5-MeO-MiPT, 5-methoxy MiPT

5-MeO-MiPT is a hallucinogenic and psychedelic drug that is commonly used as an entheogen. It has similar properties to the drugs 5-MeO-DiPT and DiPT. It is also commonly referred to as a substitute of 5-MeO-DiPT.

5-MeO-MiPT is produced through the interaction of tryptamines, such as 5-MeO-DMT and 5-MeO-DiPT. Its psychoactive effects can be achieved through the activity of the serotonin receptors in the brain.

The pharmacology and synthesis of 5-MeO-MiPT were first reported in 1985 by Alexander Shulgin and David Repke. The effects of this drug on humans were detailed in their book, which was entitled Tryptamines I Have Known and Love.

According to some users, 5-MeO-MiPT’s effects are highly stimulating and entactogenic. They report experiencing a variety of physical and tactile effects that can enhance sexual pleasure and libido. Some users also experience an unpleasant “body load,” which can be caused by nausea and muscle tension.

Although 5-MeO-MiPT has a limited history of human use, it is widely available online as a research chemical. Because of its potential side effects, it is highly advised to avoid using it.

Chemistry

5-MeO-MiPT or 5-Methoxy-N-isopropyltritryptamine is a synthetic indole Alkaloid that belongs to the Tryptamines class. Like other Tryptamines, 5-MeO-MiPT has a core structure that consists of a bicylic indore heterocycle and an ethyl side chain. It is substituted for R5 by a methoxy functional group known as CH3O.

Pharmacology

The effects of 5-MeO-MiPT are believed to be derived from its ability to act as a partial agonist of the 5-HT2A receptor. It can also be used to treat other conditions, such as the treatment of gastrointestinal disorders. However, it is not yet known if this drug can also be used to prevent the development of MAO. 5-MeO-MiPT also shows strong binding affinities to the SERT and NET, which makes it a potent inhibitor of serotonin-norepinephrine reuptake.

The mechanisms by which 5-MeO-MiPT can cause anxiolytic and anti-depressant effects are also known to explain the anecdotal reports of these conditions. For instance, certain types of antidepressants, such as venlafaxine and 5-HT1A agonist buspirone, are commonly used to treat anxiety.

The toxicological and physiological properties of this compound has not been analyzed. Usage of this Chemical should be for research and forensic purposes only.

WARNING This product is not for human or veterinary use.

This product is only available to persons of 21 years old and above.

Hazard statement(s)